IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy

Sialorrhea is a severe medical problem that is difficult to treat, which can lead to serious complications. In almost all cases, chronic sialorrhea is accompanied by a restriction of the child's contacts with peers, socialization difficulties, and a significant decrease in the quality of life....

Full description

Bibliographic Details
Published in:	Неврология, нейропсихиатрия, психосоматика
Main Authors:	A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2021-08-01
Subjects:	infantile cerebral palsy sialorrhea salivation incobotulinumtoxina botulinum therapy drooling impact scale global impression of change scale
Online Access:	https://nnp.ima-press.net/nnp/article/view/1628

Similar Items

Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea
by: A. L. Kurenkov, et al.
Published: (2022-04-01)

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
by: Koji Makino, et al.
Published: (2020-03-01)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
by: Steffen Berweck, et al.
Published: (2022-08-01)

Drooling in Patients with Cerebral Palsy: The Effectiveness of Botulinum Toxin A Treatment
by: O. A. Klochkova, et al.
Published: (2015-11-01)

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults
by: Wolfgang H. Jost, et al.
Published: (2023-05-01)

Feasibility and structure of a state hospital botulinum neurotoxin clinic for clozapine-induced sialorrhea
by: Ai-Li W. Arias, et al.
Published: (2025-08-01)

The Role of Speech Therapy in Sialorrhea Management and Quality of Life: A Retrospective Study
by: Sofia Eva Olsson, et al.
Published: (2025-02-01)

Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
by: Shang-An Hung, et al.
Published: (2021-11-01)

Sialorrhea in Parkinson’s Disease
by: Jonathan Isaacson, et al.
Published: (2020-10-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report
by: Ozge Kilic, et al.
Published: (2017-10-01)

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
by: Santamato A
Published: (2016-01-01)

Facial expression analysis to uncover the relationship between sialorrhea and hypomimia in Parkinson’s disease
by: Eline Serbée, et al.
Published: (2025-10-01)

Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial
by: David Faustino Ângelo, et al.
Published: (2023-06-01)

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Alberto Albanese, et al.
Published: (2023-05-01)

Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST Trial
by: Rajesh Pahwa, et al.
Published: (2025-06-01)

Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women
by: Ada Trindade de Almeida, et al.
Published: (2024-07-01)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Jörg Wissel, et al.
Published: (2021-12-01)

The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea
by: Özgür Sürmelioğlu, et al.
Published: (2018-06-01)

Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01)

Bilateral submandibular duct relocation for chronic sialorrhea: a 15 years of experience in children with a neurological disorder
by: Turki Imen Mehri
Published: (2023-01-01)

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
by: Franco Molteni, et al.
Published: (2023-12-01)

Botulinum toxin in the treatment of sialorrhea
by: Svetel Marina, et al.
Published: (2009-01-01)

Treatment of sialorrhea in Parkinson’s disease
by: Sahil Mehta, et al.
Published: (2022-01-01)

Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report
by: Michael Uwe Martin, et al.
Published: (2024-10-01)

Single-Dose <i>IncobotulinumtoxinA</i> in the Treatment of Early-Stage Knee Osteoarthritis: Results from a Preliminary Single-Arm Clinical Trial
by: Sofia Durán-Hernández, et al.
Published: (2025-04-01)

Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review)
by: A. L. Kurenkov, et al.
Published: (2024-02-01)

Ultrasound-guided Botulinum Toxin Injection into the Salivary Glands for Treating Sialorrhea in a Case of Small-cell Lung Cancer
by: Murat Çabalar, et al.
Published: (2023-08-01)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
by: Bruno Bergmans, et al.
Published: (2023-01-01)

EXPERIENCE OF THE TYPE A BOTULINUM TOXIN TYPE (ONABOTULINUMTOXINA) DRUG IN TREATMENT OF CEREBRAL PALSY PATIENTS
by: A. L. Kurenkov, et al.
Published: (2017-12-01)

Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea
by: Michael A. Hast, et al.
Published: (2024-08-01)

Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)

Botulinum toxin type A chemodenervation treatment in spastic forms of cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

Prevalence of Drooling among 5–10 Year-old Cerebral Palsy Children in Chennai: A Cross-sectional Study
by: Subramanian Anu Krishna Kumar, et al.
Published: (2024-07-01)

Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy
by: Mengmeng Shao, et al.
Published: (2023-08-01)

Efficacy of Relocation of Submandibular Duct in Cerebral Palsy Patients with Drooling
by: Periyanan Puraviappan, et al.
Published: (2007-07-01)

Use of botulinum toxin type A (Botox) in the treatment of infantile cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

The effectiveness of ultrasound‐guided injection of BTX‐A in the management of sialorrhea in neurogenic dysphagia patients
by: Zitong He, et al.
Published: (2023-12-01)

Is chemodenervation with incobotulinumtoxinA an alternative to invasive chronic anal fissure treatments?
by: T. Calderón, et al.
Published: (2024-09-01)

Investigating Clozapine-induced Sialorrhea Improvement in Highland Climate Area: A Case Study
by: Amir Asadi, et al.
Published: (2024-10-01)